# healthdatainsight.org.uk

> Delivering NHS information and intelligence for patients, the public and health care professionals

---


## Pages

- [Services](https://healthdatainsight.org.uk/services/)
- [Data Services](https://healthdatainsight.org.uk/data-services/)
- [Project Management](https://healthdatainsight.org.uk/project-management/)
- [Technology Solutions](https://healthdatainsight.org.uk/technology-solutions/)
- [Consultancy](https://healthdatainsight.org.uk/consultancy/)
- [Partnerships](https://healthdatainsight.org.uk/partnerships/)
- [Health Data Insight CIC](https://healthdatainsight.org.uk/)
- [HDI publications in association with NDRS](https://healthdatainsight.org.uk/hdi-publications-in-association-with-ndrs/)
- [All archived projects](https://healthdatainsight.org.uk/all-archived-projects/)
- [Publications](https://healthdatainsight.org.uk/publications/)
- [Careers](https://healthdatainsight.org.uk/careers/)
- [Privacy Policy](https://healthdatainsight.org.uk/privacy-policy/)
- [The Board](https://healthdatainsight.org.uk/the-board/)
- [News](https://healthdatainsight.org.uk/news/)
- [Information Governance](https://healthdatainsight.org.uk/information-governance/)
- [About](https://healthdatainsight.org.uk/about-hdi/)
- [Contact](https://healthdatainsight.org.uk/contact/)

---


---


## Posts

- [Synthetic Data Demonstrates Major Benefits for Cancer Research](https://healthdatainsight.org.uk/synthetic-data-demonstrates-major-benefits-for-cancer-research/)
- [Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health records](https://healthdatainsight.org.uk/long-term-health-outcomes-of-bilateral-salpingo-oophorectomy-in-brca1-and-brca2-pathogenic-variant-carriers-with-personal-history-of-breast-cancer-a-retrospective-cohort-study-using-linked-electronic/)
- [Leveraging Synthetic Data to Facilitate Research: A Collaborative Model for Analyzing Sensitive National Cancer Registry Data in England](https://healthdatainsight.org.uk/leveraging-synthetic-data-to-facilitate-research-a-collaborative-model-for-analyzing-sensitive-national-cancer-registry-data-in-england/)
- [Post Endoscopy Upper Gastrointestinal Cancer (PEUGIC) presentations at ESGE days 2025](https://healthdatainsight.org.uk/post-endoscopy-upper-gastrointestinal-cancer-peugic-presentations-at-esge-days-2025/)
- [The causes of post endoscopy upper gastrointestinal cancer in patients undergoing surveillance endoscopy: results from the English National Root Cause Analysis project.](https://healthdatainsight.org.uk/the-causes-of-post-endoscopy-upper-gastrointestinal-cancer-in-patients-undergoing-surveillance-endoscopy-results-from-the-english-national-root-cause-analysis-project/)
- [New study investigates long-term health risks after ovary and fallopian tube removal in women with previous history of breast cancer](https://healthdatainsight.org.uk/new-study-investigates-long-term-health-risks-after-ovary-and-fallopian-tube-removal-in-women-with-previous-history-of-breast-cancer/)
- [Organisational factors and Post Endoscopy Upper Gastrointestinal Cancer (PEUGIC): results of the English national PEUGIC project.](https://healthdatainsight.org.uk/organisational-factors-and-post-endoscopy-upper-gastrointestinal-cancer-peugic-results-of-the-english-national-peugic-project/)
- [First Endometrial Cancer Audit Pilot (ECAP) Report Published](https://healthdatainsight.org.uk/first-endometrial-cancer-audit-pilot-ecap-report-published/)
- [The causes of Post Endoscopy Upper Gastrointestinal Cancer: results from the English national root cause analysis project](https://healthdatainsight.org.uk/the-causes-of-post-endoscopy-upper-gastrointestinal-cancer-results-from-the-english-national-root-cause-analysis-project/)
- [The causes of Post Endoscopy Upper Gastrointestinal Cancer in patients undergoing diagnostic endoscopy](https://healthdatainsight.org.uk/the-causes-of-post-endoscopy-upper-gastrointestinal-cancer-in-patients-undergoing-diagnostic-endoscopy/)
- [First-line treatment patterns and overall survival in patients diagnosed with metastatic Merkel cell carcinoma in England from 2013 to 2020: results of a nationwide observational cohort study.](https://healthdatainsight.org.uk/first-line-treatment-patterns-and-overall-survival-in-patients-diagnosed-with-metastatic-merkel-cell-carcinoma-in-england-from-2013-to-2020-results-of-a-nationwide-observational-cohort-study/)
- [Long-term outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer](https://healthdatainsight.org.uk/long-term-outcomes-of-bilateral-salpingo-oophorectomy-in-women-with-personal-history-of-breast-cancer/)
- [Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers](https://healthdatainsight.org.uk/second-primary-cancer-risks-after-breast-cancer-in-brca1-and-brca2-pathogenic-variant-carriers/)
- [Treatment patterns and clinical outcomes in patients with metastatic urothelial carcinoma in England: A retrospective observational study](https://healthdatainsight.org.uk/treatment-patterns-and-clinical-outcomes-in-patients-with-metastatic-urothelial-carcinoma-in-england-a-retrospective-observational-study/)
- [Multiple Myeloma – Real-World Insights from nationally collected cancer data](https://healthdatainsight.org.uk/multiple-myeloma-real-world-insights-from-nationally-collected-cancer-data/)
- [Endometrial Cancer treatment and survival study published in BMJ Open](https://healthdatainsight.org.uk/endometrial-cancer-treatment-and-survival-study-published-in-bmj-open/)
- [Characteristics, Treatment Patterns, and Survival of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma in England: Results of a Nationwide Cohort Study.](https://healthdatainsight.org.uk/characteristics-treatment-patterns-and-survival-of-patients-with-locally-advanced-or-metastatic-renal-cell-carcinoma-in-england-results-of-a-nationwide-cohort-study/)
- [Ioana Preda](https://healthdatainsight.org.uk/ioana-preda/)
- [Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England](https://healthdatainsight.org.uk/real-world-characteristics-and-outcomes-of-patients-with-multiple-myeloma-receiving-second-line-treatment-in-england/)
- [Real-world patient characteristics and survival outcomes in patients with advanced or recurrent endometrial cancer in England: a retrospective, population-based study](https://healthdatainsight.org.uk/real-world-patient-characteristics-and-survival-outcomes-in-patients-with-advanced-or-recurrent-endometrial-cancer-in-england-a-retrospective-population-based-study/)
- [Study reveals variability in kidney cancer treatment and survival](https://healthdatainsight.org.uk/study-reveals-variability-in-kidney-cancer-treatment-and-survival/)
- [2024 interns prototype a low-cost and low-tech solution to track hospital equipment location and status](https://healthdatainsight.org.uk/2024-internship-news/)
- [Analysis of patients in England with advanced urothelial carcinoma suggests high unmet need](https://healthdatainsight.org.uk/analysis-of-patients-in-england-with-advanced-urothelial-carcinoma-suggests-high-unmet-need/)
- [Variability in Kidney Cancer Treatment and Survival in England](https://healthdatainsight.org.uk/variability-in-kidney-cancer-treatment-and-survival-in-england/)
- [New partnership to assess variation in the management and outcomes of endometrial cancer](https://healthdatainsight.org.uk/new-partnership-to-assess-variation-in-the-management-and-outcomes-of-endometrial-cancer/)
- [Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based study](https://healthdatainsight.org.uk/factors-associated-with-receipt-of-systemic-anticancer-treatment-for-locally-advanced-or-metastatic-urothelial-carcinoma-in-england-a-population-based-study/)
- [PEUGIC data collection – an amazing collaborative achievement!](https://healthdatainsight.org.uk/peugic-data-collection-an-amazing-collaborative-achievement/)
- [A comparison of frailty measures in population-based data for patients with colorectal cancer](https://healthdatainsight.org.uk/a-comparison-of-frailty-measures-in-population-based-data-for-patients-with-colorectal-cancer/)
- [Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study](https://healthdatainsight.org.uk/risks-of-second-primary-cancers-among-584965-female-and-male-breast-cancer-survivors-in-england-a-25-year-retrospective-cohort-study/)
- [Melissa Gannon](https://healthdatainsight.org.uk/melissa-gannon/)
- [Merkel cell carcinoma poster presented at ESMO Congress 2023](https://healthdatainsight.org.uk/merkel-cell-carcinoma-poster-presented-at-esmo-congress-2023/)
- [Nicholas Robinson](https://healthdatainsight.org.uk/nicholas-robinson/)
- [The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource](https://healthdatainsight.org.uk/the-comprehensive-english-national-lynch-syndrome-registry-development-and-description-of-a-new-genomics-data-resource/)
- [Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway](https://healthdatainsight.org.uk/identification-of-people-with-lynch-syndrome-from-those-presenting-with-colorectal-cancer-in-england-baseline-analysis-of-the-diagnostic-pathway/)
- [Simulacrum version 2 - unlocking cancer data with a richer view of treatment pathways](https://healthdatainsight.org.uk/simulacrum-version-2-unlocking-cancer-data-with-a-richer-view-of-treatment-pathways/)
- [Cohort study to assess geographical variation in cholangiocarcinoma treatment in England](https://healthdatainsight.org.uk/cohort-study-to-assess-geographical-variation-in-cholangiocarcinoma-treatment-in-england/)
- [HDI data analysts publish paper on geographical variation in cholangiocarcinoma treatment in England](https://healthdatainsight.org.uk/hdi-data-analysts-publish-paper-on-geographical-variation-in-cholangiocarcinoma-treatment-in-england/)
- [PEUGIC portal is now live!](https://healthdatainsight.org.uk/peugic-portal-is-now-live/)
- [Real-world evidence for patient outcomes and mutational burden in non-small cell lung (NSCLC) cancer patients in England using EGFR biomarker test data from routine clinical care](https://healthdatainsight.org.uk/real-world-evidence-for-patient-outcomes-and-mutational-burden-in-non-small-cell-lung-nsclc-cancer-patients-in-england-using-egfr-biomarker-test-data-from-routine-clinical-care/)
- [Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from routine clinical practice in England](https://healthdatainsight.org.uk/real-world-outcomes-and-biomarker-testing-in-cancer-patients-exploration-of-a-novel-genetic-database-from-routine-clinical-practice-in-england/)
- [First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: Results of a nationwide observational cohort study](https://healthdatainsight.org.uk/first-line-treatment-patterns-and-overall-survival-of-patients-with-advanced-merkel-cell-carcinoma-in-england-from-2013-2022-results-of-a-nationwide-observational-cohort-study-2/)
- [First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: results of a nationwide observational cohort study](https://healthdatainsight.org.uk/first-line-treatment-patterns-and-overall-survival-of-patients-with-advanced-merkel-cell-carcinoma-in-england-from-2013-2022-results-of-a-nationwide-observational-cohort-study/)
- [Filis Liu](https://healthdatainsight.org.uk/filis-liu/)
- [HDI Internship Programme](https://healthdatainsight.org.uk/hdi-internship-programme/)
- [HDI data analysts support the AMMF Cholangiocarcinoma Data Project](https://healthdatainsight.org.uk/hdi-data-analysts-support-the-ammf-cholangiocarcinoma-data-project/)
- [2023 Interns develop low-cost solutions to equipment tracking and people navigation in hospital settings](https://healthdatainsight.org.uk/2023-interns-develop-low-cost-solutions-to-equipment-tracking-and-people-navigation-in-hospital-settings/)
- [Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England](https://healthdatainsight.org.uk/evidence-into-practice-a-national-cohort-study-of-nice-recommended-oncological-drug-therapy-utilisation-among-women-diagnosed-with-invasive-breast-cancer-in-england/)
- [P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional treatment in England](https://healthdatainsight.org.uk/p47-treatment-pathways-of-patients-diagnosed-with-hepatocellular-carcinoma-hcc-after-initial-locoregional-treatment-in-england/)
- [Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis](https://healthdatainsight.org.uk/estimating-surgery-radiotherapy-and-systemic-anti-cancer-therapy-treatment-costs-for-cancer-patients-by-stage-at-diagnosis/)
- [Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer](https://healthdatainsight.org.uk/outcomes-of-dostarlimab-versus-chemotherapy-in-post-platinum-patients-with-recurrent-advanced-endometrial-cancer/)
- [Treatments into Routine Clinical Practice for the Treatment of Patients with Advanced or Metastatic Cancers](https://healthdatainsight.org.uk/treatments-into-routine-clinical-practice-for-the-treatment-of-patients-with-advanced-or-metastatic-cancers/)
- [Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data](https://healthdatainsight.org.uk/completeness-of-endocrine-therapy-information-in-the-primary-care-prescription-database-pcpd-and-secondary-care-treatment-datasets-a-national-population-based-cohort-study-using-routine-healthcare/)
- [PEUGIC portal piloted by 13 NHS organisations to enhance endoscopy quality](https://healthdatainsight.org.uk/peugic-portal-piloted-by-13-nhs-organisations-to-enhance-endoscopy-quality/)
- [Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017](https://healthdatainsight.org.uk/regional-variation-in-routes-to-diagnosis-of-cholangiocarcinoma-in-england-from-2006-to-2017/)
- [Variation in Rates of Post-Mastectomy Radiotherapy Among Women with Early Invasive Breast Cancer in England and Wales: A Population-Based Cohort Study.](https://healthdatainsight.org.uk/variation-in-rates-of-post-mastectomy-radiotherapy-among-women-with-early-invasive-breast-cancer-in-england-and-wales-a-population-based-cohort-study/)
- [Innovative Insights and Collaborative Spirit: Highlights from the 2023 HDI Symposium](https://healthdatainsight.org.uk/innovative-insights-and-collaborative-spirit-highlights-from-the-2023-hdi-symposium/)
- [Roger Cherry](https://healthdatainsight.org.uk/roger-cherry/)
- [Clinical characteristics, treatments and outcomes in patients diagnosed with hepatocellular carcinoma (HCC) receiving locoregional treatment in England](https://healthdatainsight.org.uk/clinical-characteristics-treatments-and-outcomes-in-patients-diagnosed-with-hepatocellular-carcinoma-hcc-receiving-locoregional-treatment-in-england/)
- [Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018](https://healthdatainsight.org.uk/sebaceous-carcinoma-epidemiology-associated-malignancies-and-lynch-muir-torre-syndrome-screening-in-england-from-2008-to-2018/)
- [Long-term health outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer](https://healthdatainsight.org.uk/long-term-health-outcomes-of-bilateral-salpingo-oophorectomy-in-women-with-personal-history-of-breast-cancer/)
- [Amivantamab Versus Alternative Real-World Anti-Cancer Therapies in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in the US and Europe](https://healthdatainsight.org.uk/amivantamab-versus-alternative-real-world-anti-cancer-therapies-in-patients-with-advanced-non-small-cell-lung-cancer-with-epidermal-growth-factor-receptor-exon-20-insertion-mutations-in-the-us-and-eur/)
- [HDI Symposium requirements](https://healthdatainsight.org.uk/hdi-symposium-requirements/)
- [Trends in incidence, treatment and survival of Merkel cell carcinoma epidemiology in England 2004-2018](https://healthdatainsight.org.uk/trends-in-incidence-treatment-and-survival-of-merkel-cell-carcinoma-epidemiology-in-england-2004-2018/)
- [An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations](https://healthdatainsight.org.uk/an-adjusted-treatment-comparison-comparing-amivantamab-versus-real-world-clinical-practice-in-europe-and-the-united-states-for-patients-with-advanced-non-small-cell-lung-cancer-with-activating-epiderm/)
- [Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996–2020](https://healthdatainsight.org.uk/germline-mismatch-repair-mmr-gene-analyses-from-english-nhs-regional-molecular-genomics-laboratories-1996-2020/)
- [Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.](https://healthdatainsight.org.uk/cohort-profile-of-the-sloane-project-methodology-for-a-prospective-uk-cohort-study-of-15-000-women-with-screen-detected-non-invasive-breast-neoplasia/)
- [Second primary cancer risks for female and male breast cancer survivors](https://healthdatainsight.org.uk/second-primary-cancer-risks-for-female-and-male-breast-cancer-survivors/)
- [Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations](https://healthdatainsight.org.uk/amivantimab-versus-real-world-clinical-practice-in-europe-and-the-us-for-patients-with-advanced-non-small-cell-lung-cancer-with-activating-epidermal-growth-factor-receptor-exon-20-insertion-mutations/)
- [Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England](https://healthdatainsight.org.uk/characteristics-treatment-patterns-and-outcomes-of-patients-with-newly-diagnosed-advanced-ovarian-cancer-aoc-in-england/)
- [The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project.](https://healthdatainsight.org.uk/the-presentation-management-and-outcome-of-patients-with-ductal-carcinoma-in-situ-dcis-with-microinvasion-invasion-%e2%89%a41-mm-in-size-results-from-the-uk-sloane-project/)
- [2022 Interns work on improving patient flow in a hospital setting](https://healthdatainsight.org.uk/2022-interns-work-on-improving-patient-flow-in-a-hospital-setting/)
- [Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic](https://healthdatainsight.org.uk/change-in-the-use-of-fractionation-in-radiotherapy-used-for-early-breast-cancer-at-the-start-of-the-covid-19-pandemic/)
- [Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England](https://healthdatainsight.org.uk/factors-associated-with-the-receipt-of-systemic-treatment-tx-for-metastatic-urothelial-carcinoma-muc-in-england/)
- [Evolution of the treatment landscape in patients with advanced or metastatic cancers following the approval of immuno-oncology treatments](https://healthdatainsight.org.uk/evolution-of-the-treatment-landscape-in-patients-with-advanced-or-metastatic-cancers-following-the-approval-of-immuno-oncology-treatments/)
- [Previously treated recurrent or advanced endometrial cancer in England: a real-world observational analysis](https://healthdatainsight.org.uk/previously-treated-recurrent-or-advanced-endometrial-cancer-in-england-a-real-world-observational-analysis/)
- [Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.](https://healthdatainsight.org.uk/genomic-analysis-defines-clonal-relationships-of-ductal-carcinoma-in-situ-and-recurrent-invasive-breast-cancer/)
- [Kidney Cancer UK Quality Performance Audit of Kidney Cancer Services in England](https://healthdatainsight.org.uk/kidney-cancer-uk-quality-performance-audit-of-kidney-cancer-services-in-england/)
- [Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R) endometrial cancer (EC) in England](https://healthdatainsight.org.uk/comparison-of-survival-outcomes-between-dostarlimab-and-comparator-treatments-tx-in-patients-pts-with-advanced-recurrent-a-r-endometrial-cancer-ec-in-england/)
- [An overview on synthetic administrative data for research](https://healthdatainsight.org.uk/an-overview-on-synthetic-administrative-data-for-research/)
- [Short-term mortality in ovarian, fallopian tube ad primary peritoneal carcinomas across England](https://healthdatainsight.org.uk/short-term-mortality-in-ovarian-fallopian-tube-ad-primary-peritoneal-carcinomas-across-england/)
- [Lisa Franklin](https://healthdatainsight.org.uk/lisa-franklin/)
- [Rebeca Fiadeiro](https://healthdatainsight.org.uk/rebeca-fiadeiro/)
- [Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study).](https://healthdatainsight.org.uk/breast-screening-atypia-and-subsequent-development-of-cancer-protocol-for-an-observational-analysis-of-the-sloane-database-in-england-sloane-atypia-cohort-study/)
- [Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study.](https://healthdatainsight.org.uk/unresected-screen-detected-ductal-carcinoma-in-situ-outcomes-of-311-women-in-the-forget-me-not-2-study/)
- [2022 HDI Project](https://healthdatainsight.org.uk/2022-hdi-project/)
- [Artificial Intelligence in Drug Design: Opportunities and Challenges](https://healthdatainsight.org.uk/artificial-intelligence-in-drug-design-opportunities-and-challenges/)
- [2021 interns create TheatreCapture](https://healthdatainsight.org.uk/2021-interns-create-theatrecapture/)
- [Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting](https://healthdatainsight.org.uk/demographics-and-survival-outcomes-in-patients-with-advanced-or-recurrent-endometrial-cancer-ec-following-platinum-based-doublet-pbd-in-the-english-real-world-rw-setting/)
- [A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody therapy in England](https://healthdatainsight.org.uk/a-registry-study-of-relapsed-or-refractory-multiple-myeloma-pre-exposed-to-3-or-more-therapies-including-a-proteasome-inhibitor-an-immunomodulatory-agent-and-cd38-targeted-monoclonal-antibody-therapy/)
- [Clare Pearson](https://healthdatainsight.org.uk/clare-pearson/)
- [Surgical decisions in older women with early breast cancer: patient and disease factors](https://healthdatainsight.org.uk/surgical-decisions-in-older-women-with-early-breast-cancer-patient-and-disease-factors/)
- [Updated version of Simulacrum released](https://healthdatainsight.org.uk/updated-version-of-simulacrum-released/)
- [Significant variation in treatment and survival outcomes in stage 2–4 ovarian cancer in England](https://healthdatainsight.org.uk/significant-variation-in-treatment-and-survival-outcomes-in-stage-2-4-ovarian-cancer-in-england/)
- [Utilising Public Health England Datasets to Establish a Standing Cohort of Patients with Metastatic Bladder Cancer](https://healthdatainsight.org.uk/utilising-public-health-england-datasets-to-establish-a-standing-cohort-of-patients-with-metastatic-bladder-cancer/)
- [Running an intern scheme in a global pandemic](https://healthdatainsight.org.uk/running-an-intern-scheme-in-a-global-pandemic/)
- [Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane project.](https://healthdatainsight.org.uk/pathological-features-of-11337-patients-with-primary-ductal-carcinoma-in-situ-dcis-and-subsequent-events-results-from-the-uk-sloane-project/)
- [Geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England](https://healthdatainsight.org.uk/geographic-variation-in-ovarian-fallopian-tube-and-primary-peritoneal-cancer-treatment-in-england/)
- [Gavin Baily](https://healthdatainsight.org.uk/gavin-baily/)
- [David Bower](https://healthdatainsight.org.uk/david-bower/)
- [Richard Jeavons](https://healthdatainsight.org.uk/richard-jeavons/)
- [Hilary Wilderspin](https://healthdatainsight.org.uk/hilary-wilderspin/)

---